Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.86%
#2 Pons Pons +33.93%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.17%
#4 Starpower Starpower +28.77%
#5 SkyAI SkyAI +23.54%
#6 TENDIES TENDIES +23.41%
#7 Mubarak Mubarak +22.85%
#8 StonkBroker StonkBroker +21.88%
#9 Ocean Protocol Ocean Protocol +21.10%
#10 PondCoin PondCoin +20.54%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rank in Stocks #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Share Price
$151.22
Market Cap
$373.47B
Change (1 day)
11.61%
Change (1 year)
78.05%
Country
US
Trade Merck & Co., Inc. (MRK)

Category

Healthcare
Number of shares outstanding for Merck & Co., Inc. (MRK)
Number of shares outstanding as of June 2026: 0.00
According to Merck & Co., Inc. latest financial reports and stock price the company's current number of shares outstanding is 0.00. At the end of December 2024 the company had 2.53B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Merck & Co., Inc. (MRK) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 0.00 -100.00%
2025 2.51B -0.97%
2024 2.53B -2.88%
2023 2.61B 2.97%
2022 2.53B 0.08%
2021 2.53B 0.00%
2020 2.53B -1.36%
2019 2.57B -1.06%
2018 2.59B -3.86%
2017 2.70B -1.90%
2016 2.75B -1.16%
2015 2.78B -2.01%
2014 2.84B -3.05%
2013 2.93B -3.27%
2012 3.03B -0.47%
2011 3.04B -1.75%
2010 3.10B 46.79%
2009 2.11B -1.29%
2008 2.14B -1.59%
2007 2.17B -0.33%
2006 2.18B -0.88%
2005 2.20B -0.99%
2004 2.22B -0.79%
2003 2.24B -0.92%
2002 2.26B -1.35%
2001 2.29B -0.81%
2000 2.31B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M -
CH
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 1.91B -
CH